Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07491861 · ClinicalTrials.gov registry record · NA
Mindfulness-Based Stress Reduction for Emotional Recovery After Stroke
A NA study, sponsored by HealthPartners Institute.
- Active
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT07491861: Active NA study, sponsored by HealthPartners Institute.
NCT07491861 is a NA study that is active but no longer recruiting, run by HealthPartners Institute. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07491861, a NA study, is active but no longer recruiting, sponsored by HealthPartners Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The goal of this pilot study is to examine the feasibility, acceptability, and preliminary effects of mindfulness-based stress reduction (MBSR) on interoception (your understanding of your body's internal senses), emotional well-being, and whole person health. A total of 30 people with chronic stroke will be enrolled in this study to participate in an MBSR course, consisting of a 30-minute intake visit, 8 sessions lasting 2.5 hours plus a 1-day 7-hour retreat. Participants will be randomized into either the first MBSR course (immediate start) or the second MBSR course (delayed start/waitlist control).
Primary Outcome
Feasibility of the MBSR intervention will be assessed by measuring attendance of the sessions
Interventions
- BEHAVIORAL Mindfulness-Based Stress Reduction (MBSR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2026-04-09 |
| Est. Completion | 2026-12 |
| Phase | NA |
What the registry record for NCT07491861 still lists
NCT07491861 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Mindfulness-Based Stress Reduction (MBSR) is the first listed.
NCT07491861 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07491861 about?
NCT07491861 is a clinical study titled "Mindfulness-Based Stress Reduction for Emotional Recovery After Stroke". The goal of this pilot study is to examine the feasibility, acceptability, and preliminary effects of mindfulness-based stress reduction (MBSR) on interoception (your understanding of your body's internal senses), emotional well-being, and whole person health. A total of 30 people with chronic strok...
What is the current status of trial NCT07491861?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 28 participants. The study started on 2026-04-09. Estimated completion is 2026-12.
What interventions are being tested in trial NCT07491861?
The interventions under investigation include: Mindfulness-Based Stress Reduction (MBSR) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07491861?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07491861's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI